#evaluate(de(' #AdditionalMetaTags# '))#
GratXray is an innovative medical device company, developing, producing and marketing systems based on phase contrast enhanced X-ray imaging. Our worldwide patented method (8 patents) is ideal for soft tissue imaging, as it provides unprecedented density contrast and tissue delineation in low absorbing tissues. We are focusing on applications, where classic X-ray systems fail or provide unsatisfied results.
Our first application using this new platform is breast cancer imaging, which we address by developing a Grating-Interferometry Breast-Computed-Tomography (GI-BCT) system. With this true volumetric 3D approach, we will provide more precise breast tumor detection without need of contrast agents. The breast can be measured without compression, massively improving patient comfort.
Tech tour presents 12 winners from Switzerland (startupticker.ch)
Alpine Techstars to attract investors (startupticker.ch)
Top 16 of the W.A. De Vigier Awards are announced (startupticker.ch)
Pionierpreis 2018: die Halbfinalisten sind bekannt (startupticker.ch)
Schweizer Technologieprojekte ausgezeichnet (startupticker.ch)
Swiss Technology Award: Die Finalisten stehen fest (startupticker.ch)
GratXray will den neuen Goldstandard für Brustkrebserkennung setzen (startupticker.ch)
GratXray will den neuen Goldstandard für Brustkrebserkennung setzen (startupticker.ch)
Development: Prototype assembly completed
Development: System design of prototype completed
Development: Design of base components completed
Development: Vertical lift started
Innosuisse: Milestone Review passed
Development: Lab prepared for gantry movement
Development: First mastectomy measured
Development: First CT images with new system.
Development: First projection images with new system.
Innosuisse: Core Coaching Acceptance
Convertible Loan
Convertible Loan
Incorporation
About GratXray
Inside Tomorrow Interview
Painless and accurate breast cancer imaging (german)